Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whet...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558619303136 |
id |
doaj-c1944b4530ad4613b1d28b360dc8c5f6 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuli Lin Bingji Li Xuguang Yang Qian Cai Weiren Liu Mengxin Tian Haoyang Luo Wei Yin Yan Song Yinghong Shi Rui He |
spellingShingle |
Yuli Lin Bingji Li Xuguang Yang Qian Cai Weiren Liu Mengxin Tian Haoyang Luo Wei Yin Yan Song Yinghong Shi Rui He Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment Neoplasia: An International Journal for Oncology Research |
author_facet |
Yuli Lin Bingji Li Xuguang Yang Qian Cai Weiren Liu Mengxin Tian Haoyang Luo Wei Yin Yan Song Yinghong Shi Rui He |
author_sort |
Yuli Lin |
title |
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment |
title_short |
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment |
title_full |
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment |
title_fullStr |
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment |
title_full_unstemmed |
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment |
title_sort |
fibroblastic fap promotes intrahepatic cholangiocarcinoma growth via mdscs recruitment |
publisher |
Elsevier |
series |
Neoplasia: An International Journal for Oncology Research |
issn |
1476-5586 |
publishDate |
2019-12-01 |
description |
Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whether fibroblastic FAP influenced ICC progression via non-T cell-related immune mechanisms. We demonstrated fibroblastic FAP expression was critical for STAT3 activation and CCL2 production, and ICC-CAFs were the primary source of CCL2 in human ICC microenvironment by using ICC-Fbs from six ICC patients. Fibroblastic knockdown of FAP significantly impaired the ability of ICC-CAFs to promote ICC growth, MDSCs infiltration and angiogenesis, which was restored by adding exogenous CCL2. Furthermore, interestingly, the tumor-promoting effect of fibroblastic FAP is dependent on MDSCs via secretion of CCL2, as depletion of Gr-1+ cells reversed the restoring effects of exogenous CCL2 on tumor growth and angiogenesis. In vitro migration assay confirmed that exogenous CCL2 could rescue the impaired ability of ICC-Fbs to attract Gr-1+ cells caused by fibroblastic FAP knockdown. In contrast, fibroblastic FAP knockdown had no effect on ICC cell proliferation and apoptotic resistance. Depletion MDSCs by anti-Gr-1 monoclonal antibody in subcutaneous transplanted tumor model abrogated tumor promotion by ICC-CAFs suggested that the pro-tumor function of Fibroblastic FAP relied on MDSCs. Mechanical, flow cytometry and chamber migration assay were conducted to find Fibroblastic FAP was required by the ability of ICC-CAFs to promote MDSC migration directly. Moreover, fibroblastic FAP knockdown had no effect on cell proliferation and apoptotic resistance. Here, we revealed the T-cell independent mechanisms underlying the ICC-promoting effect of fibroblastic FAP by attracting MDSCs via CCL2, which was mainly attributed to the ability of FAP to attract MDSCs and suggests that specific targeting fibroblastic FAP may represent a promising therapeutic strategy against ICC. |
url |
http://www.sciencedirect.com/science/article/pii/S1476558619303136 |
work_keys_str_mv |
AT yulilin fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT bingjili fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT xuguangyang fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT qiancai fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT weirenliu fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT mengxintian fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT haoyangluo fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT weiyin fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT yansong fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT yinghongshi fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment AT ruihe fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment |
_version_ |
1725031993282920448 |
spelling |
doaj-c1944b4530ad4613b1d28b360dc8c5f62020-11-25T01:43:43ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862019-12-01211211331142Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitmentYuli Lin0Bingji Li1Xuguang Yang2Qian Cai3Weiren Liu4Mengxin Tian5Haoyang Luo6Wei Yin7Yan Song8Yinghong Shi9Rui He10Department of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Institutes of Integrative Medicine, Fudan University, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaCancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai, 20032, ChinaKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai, 20032, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai, 20032, China; Corresponding authors.Department of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Corresponding authors.Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whether fibroblastic FAP influenced ICC progression via non-T cell-related immune mechanisms. We demonstrated fibroblastic FAP expression was critical for STAT3 activation and CCL2 production, and ICC-CAFs were the primary source of CCL2 in human ICC microenvironment by using ICC-Fbs from six ICC patients. Fibroblastic knockdown of FAP significantly impaired the ability of ICC-CAFs to promote ICC growth, MDSCs infiltration and angiogenesis, which was restored by adding exogenous CCL2. Furthermore, interestingly, the tumor-promoting effect of fibroblastic FAP is dependent on MDSCs via secretion of CCL2, as depletion of Gr-1+ cells reversed the restoring effects of exogenous CCL2 on tumor growth and angiogenesis. In vitro migration assay confirmed that exogenous CCL2 could rescue the impaired ability of ICC-Fbs to attract Gr-1+ cells caused by fibroblastic FAP knockdown. In contrast, fibroblastic FAP knockdown had no effect on ICC cell proliferation and apoptotic resistance. Depletion MDSCs by anti-Gr-1 monoclonal antibody in subcutaneous transplanted tumor model abrogated tumor promotion by ICC-CAFs suggested that the pro-tumor function of Fibroblastic FAP relied on MDSCs. Mechanical, flow cytometry and chamber migration assay were conducted to find Fibroblastic FAP was required by the ability of ICC-CAFs to promote MDSC migration directly. Moreover, fibroblastic FAP knockdown had no effect on cell proliferation and apoptotic resistance. Here, we revealed the T-cell independent mechanisms underlying the ICC-promoting effect of fibroblastic FAP by attracting MDSCs via CCL2, which was mainly attributed to the ability of FAP to attract MDSCs and suggests that specific targeting fibroblastic FAP may represent a promising therapeutic strategy against ICC.http://www.sciencedirect.com/science/article/pii/S1476558619303136 |